Treatment of impaired glucose metabolism and lipids by serotonin agonists and dopamine

摘要

(57) [Abstract] The present invention relates to a novel and improved method of regulating a mammal at least one of glucose metabolic body, body fat, food consumption, and lipid metabolism. In combination with nighttime administration of 5HT _1B receptor subtype agonists, both of these ₂ agonists or D or D _1, food consumption, body weight, total body fat and serum glucose value is reduced when administered in the morning.